Imipramine Blood Levels and Clinical Outcome

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Journal of Clinical Psychopharmacology

• Publication date

  1987-08-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1097/00004714-198708000-00003PMID 3624505
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cardiovascular effects of imipramine and nortriptyline in elderly patients

  2004cited by this paper
• Tricyclic antidepressants--blood level measurements and clinical outcome: an APA Task Force report. Task Force on the Use of Laboratory Tests in Psychiatry.

  1985cited by this paper
• Altered hydroxydesipramine concentrations in elderly depressed patients

  1982cited by this paper
• Concentrations of desipramine in elderly women.

  1981cited by this paper
• Endogenous depression and imipramine levels in the blood

  1980cited by this paper
• Single-dose kinetics predict steady-state concentrations on imipramine and desipramine.

  1980cited by this paper
• Imipramine and desipramine in plasma and spinal fluid: relationship to clinical response and serotonin metabolism.

  1978cited by this paper
• Studies on plasma level/effect relationships in imipramine therapy.

  1978cited by this paper
• Liquid-chromatographic procedure for tricyclic drugs and their metabolites in plasma.

  1978cited by this paper
• Steady-state kinetics of imipramine in patients

  1977cited by this paper
• Clinical implications of imipramine plasma levels for depressive illness.

  1977cited by this paper
• Imipramine: Clinical effects and pharmacokinetic variability

  1977cited by this paper
• Relationship between age and tricyclic antidepressant plasma levels.

  1977cited by this paper
• PLASMA LEVELS AND ANTIDEPRESSIVE EFFECT OF IMIPRAMINE

  1976cited by this paper
• [Plasma levels of imipramine and desmethylimipramine and antidepressant effect during controlled therapy(author's transl)].

  1975cited by this paper
• The clinical pharmacology of imipramine. Implications for therapeutics.

  1973cited by this paper
• INDIVIDUAL DIFFERENCES IN THE PHARMACOKINETICS OF MONOMETHYLATED TRICYCLIC ANTIDEPRESSANTS: ROLE OF GENETIC AND ENVIRONMENTAL FACTORS AND CLINICAL IMPORTANCE *

  1971cited by this paper
• Clinical significance of plasma imipramine levels.

  1971cited by this paper
• Plasma Levels of Imipramine and Desmethylimipramine during Therapy

  1967cited by this paper

• Molecular mechanism of EAG1 channel inhibition by imipramine binding to the PAS domain

  2023cites this paper
• Selective electrochemical detection of antidepressant drug imipramine in blood serum and urine samples using an antimony telluride-graphite nanofiber electrode

  2021cites this paper
• Interactions of nicotine and drugs used in the treatment of mental illnesses with respect to cognitive functions

  2010cites this paper
• 4. The issues of phychopharmacotherapy in the elderly: ―精神科領域疾患

  2008cites this paper
• Pharmacological Approaches to Treatment-Resistant Depression

  2008cites this paper
• Bedeutung von Cytochrom-P450-Polymorphismen für Verlauf, Erfolg und Nebenwirkungen der Therapie mit Antidepressiva

  2005cites this paper
• Die therapieresistente Depression

  2005cites this paper
• INFLUENCE OF AGEING AND CONCURRENT PSYCHOTROPIC O F TERTIARY DRUGS ON TRICYCLIC DEMETHYLATION ANTIDEPRESSANTS

  2004cites this paper
• Diagnosis and definition of treatment-resistant depression.

  2003cites this paper
• Smoking in Patients Receiving Psychotropic Medications

  2001cites this paper
• Drug metabolism as a confounding factor in PK/PD population approaches.

  1996cites this paper
• Pharmacokinetic Optimisation of Therapy with Newer Antidepressants

  1994cites this paper
• Tricyclic Antidepressant Concentrations in Plasma: An Estimate of Their Sensitivity and Specificity as a Predictor of Response

  1994cites this paper
• Psychotropic drug metabolism and clinical monitoring.

  1993cites this paper
• Prediction of steady-state plasma levels of doxepin and imipramine from single dose levels in depressed outpatients.

  1991cites this paper
• Influence of ageing and concurrent psychotropic drugs on dementhylation of tertiary tricyclic antidepressants

  1991cites this paper
• Clinical Pharmacokinetics of Imipramine and Desipramine

  1990cites this paper
• High blood concentrations of imipramine or clomipramine and therapeutic failure: a case report study using drug monitoring data.

  1989cites this paper
• The influence of the route of administration of imipramine on imipramine and desipramine blood levels.

  1989cites this paper
• Recent Developments in the Study of the Effects of Cigarette Smoking on Clinical Pharmacokinetics and Clinical Pharmacodynamics

  1989cites this paper
• Monitoring of tricyclic antidepressant plasma levels and clinical response: a review of the literature. Part II

  1989cites this paper
• Compliance duringTricyclic Antidepressant Therapy:Pharmacokinetic andAnalytical Issues

  1988influential citation
• Compliance during tricyclic antidepressant therapy: pharmacokinetic and analytical issues.

  1988cites this paper